ArticleJournal of family medicine and primary care2026
Interpretable XGBoost-SHAP model predicts short-term recurrence after first-episode acute pancreatitis.
Article in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Drinking Patterns and CT/MRI Feature-Based Nomogram Models Can More Accurately Predict Acute Alcoholic Pancreatitis Recurrence.Alcohol, clinical & experimental research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To construct an eXtreme Gradient Boosting (XGBoost) model for predicting short-term recurrence after first-episode acute pancreatitis (AP) and employ SHapley Additive exPlanations (SHAP) analysis for feature interpretation. Methods: A total of 442 patients with first-episode AP admitted to Cangzhou Central Hospital from October 2018 to June 2023 were retrospectively analyzed. The short-term recurrence was defined as a second attack after first-episode AP within 1 year. The cohort was split randomly, with 70% of the patients ( Results: Three features were determined as predictors of recurrence. They included elevated triglycerides, alcohol drinking, and pancreatic necrosis. The XGBoost model demonstrated favorable performance, achieving an AUC of 0.933 (95% CI: 0.895-0.970) in the training cohort and of 0.874 (95% CI: 0.777-0.970) in the validation cohort. The calibration curve exhibited strong consistency between the anticipated and observed values, and DCA confirmed that the XGBoost model provided great clinical benefit. SHAP analysis also proved that elevated triglycerides, alcohol drinking, and pancreatic necrosis were decisive for the effect of the XGBoost model. Conclusion: The XGBoost model can accurately predict short-term recurrence. The SHAP approach can enhance the interpretability of the machine-learning model and support clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.